Investors who bid for the Gujarat Kidney and Super Speciality Limited initial public offering (IPO) are now awaiting the final allotment outcome. The focus has shifted to the share allocation process following a three-day subscription period that saw decent demand from various investor categories.
Gujarat Kidney IPO Allotment and Key Dates
The allotment for the Gujarat Kidney IPO is most likely to be finalised on Friday, December 26, 2025. Following the successful completion of this process, the company's shares are scheduled to make their stock market debut. The listing on both the BSE and the NSE is tentatively set for Tuesday, December 30, 2025.
Subscription Response and Grey Market Premium (GMP)
The ₹251-crore public issue witnessed an overall subscription of 5.21 times the shares on offer. A breakdown reveals exceptionally strong interest from retail individual investors (RIIs), who bid for 19.04 times their reserved portion. The non-institutional investors (NIIs) category was subscribed 5.73 times, while qualified institutional buyers (QIBs) portion saw a subscription of 1.06 times.
In the unofficial grey market, the shares of Gujarat Kidney IPO are currently commanding a premium of ₹0, according to market observers like Investorgain. This zero GMP suggests the estimated listing price could be around the IPO's final issue price of ₹114 per share, indicating a flat debut.
How to Check Your Allotment Status
Investors can check the status of their Gujarat Kidney IPO share allocation online through multiple portals. Here is a guide to the process.
On the BSE Website
Visit the BSE's dedicated IPO allotment status page. Select 'Equity' as the issue type. From the 'Issue Name' dropdown menu, choose 'Gujarat Kidney and Super Speciality Ltd'. Enter your Permanent Account Number (PAN) or the application number. Click 'Search' to view your allotment details on screen.
On the NSE Website
Go to the NSE's IPO status page. Select the option for "Equity & SME IPO bid details." From the 'Select Symbol' dropdown, pick 'GKSL'. Input your PAN and application number, then submit the query to access your status.
Via the Registrar's Portal
The registrar for this issue is MUFG Intime India. Investors can visit their public issues page, select "Gujarat Kidney and Super Speciality Ltd" from the list, and enter details like DP/Client ID, PAN, or Application Number to check the outcome.
IPO Details and Use of Proceeds
The public offering was a fresh issue of up to 2.2 crore equity shares, priced in a band of ₹108 to ₹114 per share. At the upper end, the company aims to raise ₹250.8 crore.
The net proceeds from the IPO are earmarked for several strategic initiatives. A significant portion will be used to acquire Parekhs Hospital in Ahmedabad and to partly finance the consideration for the already acquired Ashwini Medical Centre. Furthermore, funds will support establishing a new hospital in Vadodara, procuring robotic equipment for this unit, and repaying certain outstanding borrowings. The balance will fuel inorganic expansion through future acquisitions and serve general corporate purposes.
Disclaimer: This information is for educational purposes only. Readers are advised to consult with a certified investment advisor before making any financial decisions.
